Glipizide
- Product NDC
- 66267-099
- 11-digit product format
- 662670099
- Labeler code
- 66267
- Product ID
- 66267-099_1f98dacb-a43e-a029-e063-6294a90a7609
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA075795
- Marketing category
- ANDA
- Marketing start
- 2002-09-25
- Substance
- GLIPIZIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X7WDT95N5C |
| Rxcui | 310488 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 66267-099-30 | 2024-08-13 | C162847 | 48780-1 | f386c64a-1422-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 66267-099-60 | 2024-08-13 | C162847 | 48780-1 | f386c64a-1422-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 66267-099-90 | 2024-08-13 | C162847 | 48780-1 | f386c64a-1422-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 66267-099-91 | 2024-08-13 | C162847 | 48780-1 | f386c64a-1422-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 66267-099-92 | 2024-08-13 | C162847 | 48780-1 | f386c64a-1422-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 66267-099-30 | 2023-01-30 | C162847 | 48780-1 | f386c64a-1422-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 66267-099-60 | 2023-01-30 | C162847 | 48780-1 | f386c64a-1422-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 66267-099-90 | 2023-01-30 | C162847 | 48780-1 | f386c64a-1422-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 66267-099-91 | 2023-01-30 | C162847 | 48780-1 | f386c64a-1422-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 66267-099-92 | 2023-01-30 | C162847 | 48780-1 | f386c64a-1422-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66267-099 | GLIPIZIDE TABLET [NUCARE PHARMACEUTICALS, INC.] | 7 | Current NDC, Legacy NDC, 5 package rows | 20240815_3e295cbc-37c1-4e25-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66267-099-30 | 66267009930 | 30 TABLET in 1 BOTTLE (66267-099-30) | 30 tablet | 2016-10-05 | 0000-00-00 | No | No | Current |
| 66267-099-60 | 66267009960 | 60 TABLET in 1 BOTTLE (66267-099-60) | 60 tablet | 2016-10-05 | 0000-00-00 | No | No | Current |
| 66267-099-90 | 66267009990 | 90 TABLET in 1 BOTTLE (66267-099-90) | 90 tablet | 2016-10-05 | 0000-00-00 | No | No | Current |
| 66267-099-91 | 66267009991 | 120 TABLET in 1 BOTTLE (66267-099-91) | 120 tablet | 2016-10-05 | 0000-00-00 | No | No | Current |
| 66267-099-92 | 66267009992 | 180 TABLET in 1 BOTTLE (66267-099-92) | 180 tablet | 2016-10-05 | 0000-00-00 | No | No | Current |